Allena Pharmaceuticals Inc (ALNA)

NASDAQ
0.1212
-0.0064(-5.02%)
After Hours
0.1250
+0.0038(+3.1353%)
- Real-time Data
  • Volume:
    14,175,940
  • Day's Range:
    0.1111 - 0.1276
  • 52 wk Range:
    0.0683 - 1.1700
Earnings results expected today

ALNA Overview

Prev. Close
0.1276
Day's Range
0.1111-0.1276
Revenue
-
Open
0.1253
52 wk Range
0.0683-1.17
EPS
-0.638
Volume
14,175,940
Market Cap
13.06M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
27,728,118
P/E Ratio
-0.215
Beta
1.15
1-Year Change
-87.76%
Shares Outstanding
107,725,169
Next Earnings Date
14 Aug 2022
What is your sentiment on Allena Pharma?
or
Market is currently closed. Voting is open during market hours.

Allena Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Allena Pharmaceuticals Inc Company Profile

Allena Pharmaceuticals Inc Company Profile

Employees
21

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell